News, views and contacts from the global Drugdevelopment industry

Today on Drug Development Technology

Xiidra Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease

Xiidra lifitegrast ophthalmic solution is a twice-a-day eye drop solution developed by Shire as a treatment for the signs and symptoms of...

Venclexta (Venetoclax) for the Treatment of Chronic Lymphocytic Leukaemia

Venclexta (Venetoclax) is an oral formulation developed by AbbVie in collaboration with Genentech and Roche, for the treatment of chronic...

June's top stories: Bayer reported positive results of RESORCE trial, TapImmune initiated Phase II trial of TPIV 200

Bayer reported positive results from the Phase III RESORCE trial of Stivarga (regorafenib) tablets to treat unresectable hepatocellular...

Zerbaxa (ceftolozane/tazobactam) for Treatment of Gram-negative Bacterial Infections

Zerbaxa (ceftolozane/tazobactam) is an antibiotic developed and marketed by Merck (formerly Cubist Pharmaceuticals (Cubist)), for the...


Latest Products & Services

Malvern Instruments
Zetasizer AT for DLS
Malvern's Zetasizer AT brings the industry leading Dynamic Light Scattering (DLS) technology of the Zetasizer Nano to the process development and manufacturing arena, enabling real...
See all products

cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_1903286115